Fabry cardiomyopathy: myocardial fibrosis, inflammation and reduced mannose6phosphate receptors cause low accessibility to enzyme therapy.
30 August 2024 (08:00 - 17:30)
Organised by: 
About the speaker
INMI Lazzaro Spallanzani Scientific Institute for Research and Healthcare, Rome (Italy)
5 More presentations in this session
Doctor D. Nelson (Melbourne, AU)
Mr E. Zulfaj (Gothenburg, SE)
Associate Professor C. Thonusin (Chiang Mai, TH)
Professor A. Barac (Fairfax, US)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024
You may be interested in
Congress Session
